A recent social media post has claimed that Covaxin, a COVID-19 vaccine, can lead to death even two years after vaccination, alleging it caused the deaths of millions across India. However, a fact check reveals these claims to be false.
The post suggests that Covaxin can cause death long after vaccination. However, there is no evidence to support this assertion. Covaxin, like other vaccines, undergoes rigorous testing for safety and efficacy before approval and is continuously monitored afterward.
Clinical trials of Covaxin have demonstrated promising safety and immunogenicity results. Additionally, the vaccine has received regulatory approvals from various authorities, including the Drugs Controller General of India (DCGI) and the World Health Organization (WHO).
Concerns have been raised regarding the suspension of Covaxin’s supply by the WHO due to manufacturing deficiencies. However, this suspension does not indicate safety concerns, and Covaxin remains safe and effective.
It’s crucial to rely on verified information from reputable sources when assessing vaccine safety and efficacy. Vaccines are essential tools in combating the COVID-19 pandemic and have been instrumental in saving lives and controlling the spread of the virus.
In conclusion, claims suggesting that Covaxin can cause death after two years of vaccination are unfounded, and the vaccine remains a vital component of global efforts to fight the pandemic.
